Detalhe da pesquisa
1.
Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.
Blood
; 143(10): 866-871, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38118071
2.
Hypoglycemia Due to Acquired Carnitine Deficiency in a Pediatric Patient Receiving Chemotherapy.
J Pediatr Hematol Oncol
; 44(2): e496-e499, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33661167
3.
Affirming Hormone Treatment for a Transgender Adolescent After a Venous Thromboembolic Event.
J Pediatr Hematol Oncol
; 44(5): e892-e895, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293883
4.
A Retrospective Review of Mercaptopurine Metabolism Reveals High Rate of Patients With Suboptimal Metabolites Successfully Corrected With Allopurinol.
J Pediatr Hematol Oncol
; 43(7): e1003-e1009, 2021 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32925411
5.
The Sickle Cell Pain Action Plan: A low health literacy, pictographic tool to enhance self-management, and guideline concordance.
Pediatr Blood Cancer
; 69(12): e29775, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35593011
6.
Reduction of Factor VIII Inhibitor Titers During Immune Tolerance Induction With Recombinant Factor VIII-Fc Fusion Protein.
Pediatr Blood Cancer
; 63(5): 922-4, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26739399
7.
Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
J Pediatr Hematol Oncol
; 38(2): 147-51, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26808368